... a tiny immuno-oncology startup based in San Antonio, filed for $25 million. These companies will try to capitalize on a 2020 biotech IPO boom that ...
News
- The biotech IPO boom is becoming 'historic' as four more throw their hats in
- Covid-19 roundup: Temasek leads a $250M raise for BioNTech as first Covid-19 mRNA vaccine ...
Temasek is leading a $250 million injection into the German biotech, one of a small pack of ... Intercept wasn't the only biotech in line for a drubbing today. ... a tiny immuno-oncology startup based in San Antonio, filed for $25 million.
- Coty, Boeing rise; Intercept Therapeutics, Heron fall
The Food and Drug Administration declined to approve the biotechnology company's liver disease drug. Coty Inc., up 56 cents to $4.74. The owner of ...
- Biopsy Devices Market to Eyewitness Massive Growth by 2026 | Boston University, Carlos III Health ...
... San Antonio, University of Twente, University of Washington, Vanderbilt University, Vascular BioSciences, Verisante Technology Inc, VitruMed Inc., ...
- Small fiber neuropathy can cause big woes
Several biotech companies are working on new drugs to treat all kinds of pain based on what has been learned from studying genetic mutations that ...